Xingguo Li[Author] - Search Results

Year	Number of Results
2002	2
2003	2
2005	4
2006	5
2007	3
2008	8
2009	6
2010	12
2011	3
2012	4
2013	5
2014	11
2015	8
2016	12
2017	14
2018	12
2019	7
2020	7
2021	8
2022	15
2023	18
2024	3

1

Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective.

Lebedev T, Kousar R, Patrick B, Usama M, Lee MK, Tan M, Li XG. Lebedev T, et al. Cells. 2023 Mar 21;12(6):952. doi: 10.3390/cells12060952. Cells. 2023. PMID: 36980292 Free PMC article. Review.

2

Carbon Nanomaterials: Emerging Roles in Immuno-Oncology.

Patrick B, Akhtar T, Kousar R, Huang CC, Li XG. Patrick B, et al. Int J Mol Sci. 2023 Apr 1;24(7):6600. doi: 10.3390/ijms24076600. Int J Mol Sci. 2023. PMID: 37047572 Free PMC article. Review.

3

Abnormal chromatin remodeling caused by ARID1A deletion leads to malformation of the dentate gyrus.

Liu PP, Lu SP, Li X, Tang GB, Liu X, Dai SK, Jiao LF, Lin XW, Li XG, Hu B, Jiao J, Teng ZQ, Han CS, Liu CM. Liu PP, et al. Cell Death Differ. 2023 Sep;30(9):2187-2199. doi: 10.1038/s41418-023-01199-w. Epub 2023 Aug 5. Cell Death Differ. 2023. PMID: 37543710

4

Using Chemistry to Target Neuroblastoma.

Hansen JN, Li X, Zheng YG, Lotta LT Jr, Dedhe A, Schor NF. Hansen JN, et al. Among authors: li x. ACS Chem Neurosci. 2017 Oct 18;8(10):2118-2123. doi: 10.1021/acschemneuro.7b00258. Epub 2017 Aug 24. ACS Chem Neurosci. 2017. PMID: 28800395 Review.

5

What nature has to offer: Opportunities for immuno-oncology.

Kousar R, Lin CH, Patrick B, He M, Wu DC, Li XG. Kousar R, et al. J Food Drug Anal. 2023 Jun 15;31(2):212-231. doi: 10.38212/2224-6614.3459. J Food Drug Anal. 2023. PMID: 37335163 Free PMC article. Review.

6

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development.

Chin Y, Gumilar KE, Li XG, Tjokroprawiro BA, Lu CH, Lu J, Zhou M, Sobol RW, Tan M. Chin Y, et al. Theranostics. 2023 Apr 17;13(7):2281-2300. doi: 10.7150/thno.82431. eCollection 2023. Theranostics. 2023. PMID: 37153737 Free PMC article. Review.

7

IRG1/Itaconate induces metabolic reprogramming to suppress ER-positive breast cancer cell growth.

Wang HC, Chang WC, Lee DY, Li XG, Hung MC. Wang HC, et al. Am J Cancer Res. 2023 Mar 15;13(3):1067-1081. eCollection 2023. Am J Cancer Res. 2023. PMID: 37034222 Free PMC article.

8

PG545 Prevents Osteoarthritis Development by Regulating PI3K/AKT/mTOR Signaling and Activating Chondrocyte Autophagy.

Guo P, Li H, Wang X, Li X, Li X. Guo P, et al. Among authors: li x. Pharmacology. 2023;108(6):576-588. doi: 10.1159/000532078. Epub 2023 Oct 11. Pharmacology. 2023. PMID: 37820587

9

Hydrogen Generation by Hydrolysis of MgH₂-LiH Composite.

Wu X, Xue H, Peng Y, Deng J, Xie Z, Zheng J, Li X, Li S. Wu X, et al. Among authors: li x. Materials (Basel). 2022 Feb 21;15(4):1593. doi: 10.3390/ma15041593. Materials (Basel). 2022. PMID: 35208133 Free PMC article.

10

USP24-dependent stabilization of Runx2 recruits a p300/NCOA3 complex to transactivate ADAMTS genes and promote degeneration of intervertebral disc in chronic inflammation mice.

Li X, Zhang J, Wang B, Chen C, Zhang E, Lv Z, He Q, Hu Y, Wang X, Zhang F. Li X, et al. Biol Direct. 2023 Jul 6;18(1):37. doi: 10.1186/s13062-023-00395-5. Biol Direct. 2023. PMID: 37415159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

154 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year